Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily.

PURPOSE To evaluate the efficacy and safety of the timolol maleate/latanoprost fixed combination (TLFC) given once each evening versus brimonidine and timolol solution given twice daily as concomitant therapy in primary open-angle glaucoma or ocular hypertension patients. METHODS Qualified subjects were begun on timolol alone twice daily for 1 month and then randomized to either TLFC or brimonidine and timolol concomitant therapy for 6 weeks. Patients were then switched to the other treatment regimen. Intraocular pressures (IOPs) were measured every 2 hours between 08 : 00 and 20 : 00 hours at baseline and at the end of periods 1 and 2. RESULTS This study found that in 32 subjects the IOP diurnal curve on timolol alone (20.9 +/- 2.8 mmHg) decreased to 17.9 +/- 3.2 mmHg when patients were treated with TLFC and to 19.0 +/- 2.4 mmHg when patients were treated with brimonidine and timolol (p = 0.02). Intraocular pressures at individual time-points were statistically similar between the groups at the 08 : 00 trough and 2 and 4 hours after dosing. However, beyond 4 hours after dosing, TLFC-treated subjects demonstrated a trend towards lower IOPs at each 2-hour time-point that was not statistically significant after a Bonferroni correction (p <or= 0.05). The incidence of both solicited and unsolicited side-effects was similar between groups. CONCLUSION This study suggests that TLFC given in the evening reduces the mean daytime diurnal IOP more than brimonidine and timolol given concomitantly twice daily.

[1]  E. Higginbotham,et al.  Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial. , 2002, Archives of ophthalmology.

[2]  A. Konstas,et al.  Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma. , 2001, American journal of ophthalmology.

[3]  W. C. Stewart,et al.  The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension. , 2001, American journal of ophthalmology.

[4]  R. Susanna,et al.  A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension. , 2001, Ophthalmology.

[5]  G. Schwartz,et al.  Therapeutic success of latanoprost 0.005% compared to brimonidine 0.2% in patients with open-angle glaucoma or ocular hypertension. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[6]  W. C. Stewart,et al.  Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure. , 2000, American journal of ophthalmology.

[7]  A. Konstas,et al.  Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension. , 2000, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[8]  W. C. Stewart,et al.  Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost. , 1999, American journal of ophthalmology.

[9]  W. C. Stewart,et al.  The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. , 1998, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[10]  M. Araie,et al.  A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. , 1996, Archives of ophthalmology.

[11]  C. Camras Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. , 1996, Ophthalmology.

[12]  J. Stjernschantz,et al.  A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. , 1996, Ophthalmology.

[13]  A. Alm,et al.  Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. , 1995, Ophthalmology.

[14]  J. Stjernschantz,et al.  Phenyl substituted prostaglandin analogs for glaucoma treatment , 1992 .

[15]  G. R. Duff A double‐masked crossover study comparing the effects of carteolol 1% and 2% on intra‐ocular pressure , 1987, Acta ophthalmologica.

[16]  Stephen A. Book Essentials of Statistics , 1977 .

[17]  S. Siegel,et al.  Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.